FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

Chronological Source Flow
Back

AI Fusion Summary

The FDA approved Wellcovorin for an ultra‑rare disease, while Trump administration officials promoted it as an autism treatment. Separately, the FDA approved Leucovorin but clarified it is not for autism, despite earlier Trump‑era promotion.
Community Comments
Loading updates...
0